DNTH · Dianthus Therapeutics, Inc. /DE/
$115.96
+6.36 (+5.80%)
At close · Aug 14
Market Cap
$6.49B
Shares
55.93M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Marino Garcia | President and Chief Executive Officer | $10,614,702 |
| Simrat Randhawa | Executive Vice President, Head of Research and Development | $5,221,537 |
| Ryan Savitz | Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | $5,074,953 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Marino Garcia | President and Chief Executive Officer | $8,843,300 |
| Simrat Randhawa | Chief Medical Officer | $4,035,266 |
| Ryan Savitz | Chief Financial Officer, Chief Business Officer and Treasurer | $4,002,145 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Stephen Mahoney | Former President, Chief Financial and Operating Officer | $1,656,676 |
| Thomas Beetham | Former Chief Legal Officer | $1,571,434 |
| Lisa Olson | Former Chief Scientific Officer | $1,128,013 |
| Jason Gardner | D.Phil. Former President and Chief Executive Officer | $667,649 |
| Marino Garcia | President and Chief Executive Officer | $496,022 |
| Simrat Randhawa | Chief Medical Officer | $338,158 |
| Ryan Savitz | Chief Financial Officer, Chief Business Officer and Treasurer | $329,651 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jason Gardner | D.Phil. Former President and Chief Executive Officer | $1,654,848 |
| Stephen Mahoney | Former President, Chief Financial and Operating Officer | $1,120,887 |
| Lisa Olson | Former Chief Scientific Officer | $983,504 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jason Gardner | D.Phil. President and Chief Executive Officer | $2,228,102 |
| Thomas Beetham | Chief Legal Officer | $1,894,380 |
| David Nichols | Chief Technical Officer | $1,661,676 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jason Gardner | D.Phil. President and Chief Executive Officer | $3,102,848 |
| Stephen Mahoney | Chief Financial and Operating Officer (7 ) | $1,959,130 |
| John C. Davis | Jr., M.D. Head of Research and Development and Chief Medical Officer | $1,762,160 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jason Ryan | Chief Operating and Financial Officer | $1,940,724 |
| Jason Gardner | D.Phil. President and Chief Executive Officer | $1,651,001 |
| John C. Davis | Jr., M.D. Head of Research and Development and Chief Medical Officer | $913,521 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Jason Gardner | D.Phil. President and Chief Executive Officer | $4,749,458 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marino Garcia | Class I director | Appointed | 2025-05-22 |
| Paula Soteropoulos | Class I director | Appointed | 2025-05-22 |
| Simon Read | Class III director | Appointed | 2025-05-22 |
| Leon O. Moulder, Jr. | member of the Board of Directors | Resigned | 2025-05-22 |
| Sujay Kango | Class II director of the Company and as a member of the Compensation Committee of the Board | Appointed | 2025-03-05 |
| Steven Romano, M.D. | member of the Science and Technology Committee | Appointed | 2024-09-16 |
| Steven Romano, M.D. | Class III director | Appointed | 2024-09-16 |
| Alison F. Lawton | Class III director | Appointed | 2024-05-28 |
| Leon O. Moulder, Jr. | Class III director | Appointed | 2024-05-28 |
| Edward Carr | Chief Accounting Officer and principal accounting officer | Appointed | 2023-09-12 |
| Ryan Savitz | Treasurer and Chief Financial Officer and principal financial officer | Appointed | 2023-09-12 |
| Marino Garcia | President and Chief Executive Officer and principal executive officer | Appointed | 2023-09-12 |
| Leon O. Moulder, Jr. | Chair of the Board of Directors | Appointed | 2023-09-12 |
| Jonathan Violin, Ph.D. | Board of Directors | Appointed | 2023-09-12 |
| Paula Soteropoulos | Board of Directors | Appointed | 2023-09-12 |
| Lei Meng | Board of Directors | Appointed | 2023-09-12 |
| Tomas Kiselak | Board of Directors | Appointed | 2023-09-12 |
| Leon O. Moulder, Jr. | Board of Directors | Appointed | 2023-09-12 |
| Anne McGeorge | Board of Directors | Appointed | 2023-09-12 |
| Marino Garcia | Board of Directors | Appointed | 2023-09-12 |
| Stephen Mahoney | President, Chief Financial and Operating Officer | Terminated | 2023-09-12 |
| Alison F. Lawton | Board of Directors | Appointed | 2023-09-12 |
| Michael Vasconcelles, M.D. | Board of Directors | Resigned | 2023-09-12 |
| David T. Scadden, M.D. | Board of Directors | Resigned | 2023-09-12 |
| Amy Lynn Ronneberg | Board of Directors | Resigned | 2023-09-12 |
Key facts
CIK
1690585
CUSIP
252828108
13F (30d)
263 filings
259 filers
Visit website
Investor relations